siRNA Library Screening for Pharmacologic Radiation Mitigators
siRNA Library Screening for Pharmacologic Radiation Mitigators
批准号:
8515296
负责人:
JOHN S. LAZO
金额:
$40.12万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdoptedAnimal ModelApoptosisBCL2 geneBiological AssayBiological MarkersCardiolipinsCell Culture TechniquesCellsCollaborationsComplexComputer AnalysisComputing MethodologiesDevelopmentDrug KineticsDrug TargetingDrug usageEnsureExposure toGeneral PopulationGenomeGlyburideHumanLeadLinkMitochondriaMolecular TargetNew AgentsNitric Oxide SynthaseNuclearOleic AcidsOxidoreductasePathway interactionsPharmaceutical ChemistryPharmaceutical PreparationsPharmacologyProteinsRNARNA InterferenceRNA libraryRadiationRadiation ToxicityRadioactiveResourcesSentinelStabilizing AgentsStandardizationStructureSystemTissuesToxic effectWaranalogcombatdesigndrug discoveryinhibitor/antagonistinnovationirradiationnanoparticlenitrationnovelprogramsscreeningsmall moleculesmall molecule libraries
中文摘要
电离辐射诱导细胞中的RNA,其可以在辐射之前被siRNA靶向以鉴定新的RNA。
辐射防护药物的靶点。我们已经成功地用这种策略来鉴定一种常见的药物,
新型抗辐射剂格列本脲。我们现在建议应用这一策略来识别辐射缓解剂
使用放射敏感的人细胞靶点和照射后siRNA筛选的药物。1** 具体目标将
优化和部署前哨细胞,用于检测新缓解药物的RNA靶点。第二个目标是
使用可药物化的siRNA文库和小分子文库来鉴定辐射损伤缓解剂。的
第三个目标是确定与优先药物积极相互作用的靶点,以促进辐射缓解
方面的影响.
英文摘要
Ionizing irradiation induces RNAs in cells which can be targeted prior to irradiation by siRNA to identify novel
targets for radioprotector drugs. We have successfully used this strategy to identify a co,mmon drug,
Glyburide, as a novel radioprotector. We now propose to apply this strategy to identify radiation mitigator
drugs using radiosensitive human cell targets and siRNA screening after irradiation. The 1** Specific Aim will
optimize and deploy sentinel cells for detecting RNA targets for new mitigator drugs. The second aim will be
to use druggable siRNA libraries and small molecule libraries to identify radiation damage mitigators. The
third aim will be to identify targets that interact positively with prioritized drugs to advance radiation mitigation
effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
-
批准号:10632154
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2022
-
负责人:JOHN S. LAZO
-
依托单位:
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
-
批准号:10330408
-
项目类别:
-
资助金额:$25.22万
-
财政年份:2021
-
负责人:JOHN S. LAZO
-
依托单位:
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
-
批准号:10540550
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2021
-
负责人:JOHN S. LAZO
-
依托单位:
Developing small molecule PTP4A3 inhibitors for ovarian cancer
-
批准号:9769367
-
项目类别:
-
资助金额:$28.93万
-
财政年份:2019
-
负责人:JOHN S. LAZO
-
依托单位:
Operetta CLS High-content Imaging System
-
批准号:9274679
-
项目类别:
-
资助金额:$51.6万
-
财政年份:2017
-
负责人:JOHN S. LAZO
-
依托单位:
PTP4A3 as a Molecular Cancer Target
-
批准号:8814295
-
项目类别:
-
资助金额:$20.42万
-
财政年份:2014
-
负责人:JOHN S. LAZO
-
依托单位:
CHEMICAL BIOLOGY FACILITY
-
批准号:8181010
-
项目类别:
-
资助金额:$9.53万
-
财政年份:2010
-
负责人:JOHN S. LAZO
-
依托单位:
siRNA Library Screening for Pharmacologic Radiation Mitigators
-
批准号:8010798
-
项目类别:
-
资助金额:$26.88万
-
财政年份:2010
-
负责人:JOHN S. LAZO
-
依托单位:
Chemical Complementation Assay for MKP-3 (RMI)
-
批准号:7057143
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
In Vitro High Throughput Screening Assay for MKP-3(RMI)
-
批准号:7058166
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7076269
-
项目类别:
-
资助金额:$334.7万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7691436
-
项目类别:
-
资助金额:$75.75万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7231271
-
项目类别:
-
资助金额:$1.99万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
In Vitro High Throughput Screening Assay for MKP-1(RMI)
-
批准号:7058173
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7277157
-
项目类别:
-
资助金额:$372.19万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Pittsburgh Molecular Libraries Screening Center(RMI)
-
批准号:7502274
-
项目类别:
-
资助金额:$16.03万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Core--Medicinal chemistry: discovery and screening
-
批准号:7055205
-
项目类别:
-
资助金额:$18.42万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
CANCER STRESS RELEVANT PROTEIN PHOSPHATASE TARGETS
-
批准号:6923496
-
项目类别:
-
资助金额:$14.86万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
Chemical Complementation Assay for MKP-1 (RMI)
-
批准号:7058509
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
MOLECULAR PHARM. AND BIOCHEM. OF NOVEL DUAL SPECIIFICITY PHOSPHATASE INHIBITORS
-
批准号:6928832
-
项目类别:
-
资助金额:$16.56万
-
财政年份:2005
-
负责人:JOHN S. LAZO
-
依托单位:
海外基金